Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pembrolizumab england patent?Premarin historical price chart?Pembrolizumab pipeline?What's lipitor's effect on synthesizing proteins?Who owns nicorette company?
See the DrugPatentWatch profile for Hemlibra
Hemlibra (emicizumab) was launched in the United States in 2018. [1]
The drug’s U.S. launch followed its FDA approval in 2017 for hemophilia A patients with inhibitors (and later expanded to additional patient groups). [1]
DrugPatentWatch tracks product and regulatory milestones, including dates tied to Hemlibra’s market launch. [1]
[1] https://www.drugpatentwatch.com/p/hemophilia-a-hemophilia-b
Other Questions About Hemlibra :